Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Mobile-Based Microlearning for Improving ICU Nurses' Adherence to Ventilator-Associated Pneumonia Prevention Protocols

NCT07866027 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-10
Last updated
2026-10-21

Condition(s) studied

Ventilator-Associated Pneumonia

Investigational drug(s) / intervention(s)

Mobile-Based Microlearning ProgramRoutine Education

Mobile-Based Microlearning Program: A mobile-based educational intervention consisting of short learning modules addressing evidence-based ventilator-associated pneumonia prevention measures, including hand hygiene, oral care, head-of-bed elevation, suctioning practices, ventilator care, and adherence to VAP prevention bundles.

Routine Education: Standard educational materials and routine institutional education related to ventilator-associated pneumonia prevention practices.

Study summary

Ventilator-associated pneumonia (VAP) is one of the most common healthcare-associated infections among mechanically ventilated patients and is associated with increased morbidity, mortality, length of intensive care unit stay, and healthcare costs. Adherence of intensive care unit (ICU) nurses to evidence-based VAP prevention protocols is essential for reducing the incidence of VAP; however, maintaining consistent adherence remains challenging.

This randomized controlled trial aims to evaluate the effectiveness of a mobile-based microlearning educational program in improving ICU nurses' adherence to VAP prevention protocols. Eligible ICU nurses will be randomly assigned to either an intervention group receiving a mobile-based microlearning program or a control group receiving routine educational resources. The microlearning program will deliver short, focused learning modules through mobile devices using multimedia content, interactive activities, reminders, and reinforcement strategies.

The primary outcome is nurses' adherence to VAP prevention practices. Secondary outcomes include nurses' knowledge regarding VAP prevention and knowledge retention over time. Findings from this study may support the integration of mobile-based microlearning approaches into continuing nursing education programs to enhance evidence-based practice in critical care settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Registered nurses working in adult intensive care units. * Providing direct care to mechanically ventilated patients. * Having at least 6 months of ICU clinical experience. * Able to read and understand English. * Owning a smartphone with internet access. * Willing to participate and provide informed consent. Exclusion Criteria: * Nurses on leave during the study period. * Administrative nurses who do not provide direct patient care. * Nurses who previously received structured training on the study microlearning program. * Nurses who decline participation or withdraw from the study.

Primary outcome measure(s)

  • ICU Nurses' Adherence to Ventilator-Associated Pneumonia Prevention Protocols — Baseline, 4 weeks post-intervention, and 8 weeks follow-up
    Adherence to ventilator-associated pneumonia prevention protocols measured using a structured observational checklist. Higher scores indicate better adherence to evidence-based VAP preventive practices.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Nursing, Alexandria University Alexandria Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07866027 on ClinicalTrials.gov ↗ ← All trials in Egypt